Ja. Kuipers et al., Recirculatory and compartmental pharmacokinetic modeling of alfentanil in pigs - The influence of cardiac output, ANESTHESIOL, 90(4), 1999, pp. 1146-1157
Citations number
29
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Background: Cardiac output (CO) is likely to influence the pharmacokinetics
of anesthetic drugs and should be accounted for in pharmacokinetic models.
The influence of CO on the pharmacokinetic parameters of alfentanil in pig
s was evaluated using compartmental and recirculatory models.
Methods: Twenty-four premedicated pigs were evaluated during halothane (0.6
-2%) anesthesia. They were assigned randomly to one of three groups. One gr
oup served as control. In the other groups, the baseline CO was decreased o
r increased by 40% by pharmacologic intervention (propranolol or dobutamine
). Boluses of alfentanil (2 mg) and indocyanine green (25 mg) were injected
into the right atrium. Blood samples were taken for 150 min from the right
atrium and aortic root. Arterial concentration-time curves of indocyanine
green and alfentanil were analyzed using compartmental models (two-stage an
d mixed-effects approach) and a recirculatory model, which can describe lun
g uptake and early distribution.
Results: The CO of individual Digs varied from 1.33 to 6.44 1/min, Three-co
mpartmental modeling showed that CO is a determinant of the central compart
ment volume (V-1, r(2) = 0.54), fast peripheral compartment volume (V-2, r(
2) = 0.29), steady state distribution volume (V-65, r(2) = 0.29), fast dist
ribution clearance (Cl-12, r(2) = 0,39), and elimination clearance (Cl-10,
r(2) = 0.51), Recirculatory modeling showed that CO is a determinant of tot
al distribution volume (r(2) = 0.48), elimination clearance (r(2) = 0.54),
and some distribution clearances. The pulmonary distribution volume was ind
ependent of CO.
Conclusions: Cardiac output markedly influences the pharmacokinetics of alf
entanil in pigs, Therefore, accounting for CO enhances the predictive value
of pharmacokinetic models of alfentanil.